About this trial
What if heart disease starts outside the heart? This research will study how to simultaneously assess brain and body physiology, how they are jointly related to heart function, and how their response to physical and mental stress differs in patients with heart disease.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18 years and older
For patients with cardiovascular disease: Documented diagnosis of ischemic heart disease based on standard clinical, radiologic, and/or histopathologic criteria, as documented in the medical record; or a clinical nuclear cardiac stress PET test within 1 year.
For healthy subjects: No diagnosis of cardiometabolic disease, cancer, or other major disease within the past 5 years
Disqualifiers
Research-related radiation exposure exceeding current MGB Radiology Department guidelines (i.e., 50 mSv in the prior 12 months);
Inability to lie comfortably on the bed inside the scanner;
Body weight > 300 lbs (weight limit of the scanner table);
Pregnancy or breastfeeding;
Trial design
Single group
Treatments tested in this trial
18F-FDG
DrugDynamic 18F-FDG PET
Positron Emission Tomography (PET)
DevicePanorama GS PET/CT
Treatment groups
Trial outcomes
Primary outcomes
Blood flow responses
The primary endpoint is to evaluate if blood flow responses to acute stressors can be quantitatively measured with 18F-FDG
Secondary outcomes
Glucose metabolism responses
The secondary endpoint is to evaluate if glucose metabolic responses to acute stressors can be quantitatively measured with 18F-FDG
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: